SUSI ROGER E. (CEO, PRESIDENT, CHAIRMAN) sold 0.2% of their position (5K shares) of IRADIMED CORP on the open market
Open‑market sale worth $428.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/19/2025ACC: 0001613801-25-000031
DirectorOfficer10% Owner· CEO, PRESIDENT, CHAIRMAN
Since Mar 2026
-5K
Net shares
Net seller
$428.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−3.18K
Price / share
$85.29
Trade value
$271.56K
% of position
0.1%
11/18/2025
2.32M→2.31M
Common Stock
Indirect
Shares
−1.82K
Price / share
$86.12
Trade value
$156.39K
% of position
0.1%
11/18/2025
2.31M→2.31M
Total
Net shares
−5K
Net value
-$427.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/18/2025 | S · Sale | −3.18K | $85.29 | $271.56K | 0.1% | 2.32M | 2.31M |
| Common Stock Indirect | 11/18/2025 | S · Sale | −1.82K | $86.12 | $156.39K | 0.1% | 2.31M | 2.31M |
| Total | −5K | -$427.96K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned162.95K
Common Stock
IndirectShares owned2.06M
Total
2.23M indirect2.23M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 162.95K | Indirect |
| Common Stock | 2.06M | Indirect |
| Total | 2.23M | 2.23M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported